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Most inbred mice carry germline proviruses of the retrovirus, mouse mammary tumor virus (MMTV) (called Mtvs),
which have multiple replication defects. A BALB/c congenic mouse strain lacking all endogenous Mtvs( Mtv-null) was
resistant to MMTV oral and intraperitoneal infection and tumorigenesis compared to wild-type BALB/c mice. Infection
of Mtv-null mice with an MMTV-related retrovirus, type B leukemogenic virus, also resulted in severely reduced viral
loads and failure to induce T-cell lymphomas, indicating that resistance is not dependent on expression of a
superantigen (Sag) encoded by exogenous MMTV. Resistance to MMTV in Mtv-null animals was not due to neutralizing
antibodies. Further, Mtv-null mice were resistant to rapid mortality induced by intragastric inoculation of the Gram-
negative bacterium, Vibrio cholerae, but susceptibility to Salmonella typhimurium was not significantly different from
BALB/c mice. Susceptibility to both MMTV and V. cholerae was reconstituted by the presence of any one of three
endogenous Mtvs located on different chromosomes and was associated with increased pathogen load. One of these
endogenous proviruses is known to encode only Sag. Therefore, Mtv-encoded Sag appears to provide a unique genetic
susceptibility to specific viruses and bacteria. Since human endogenous retroviruses also encode Sags, these studies
have broad implications for pathogen-induced responses in mice and humans.
Citation: Bhadra S, Lozano MM, Payne SM, Dudley JP (2006) Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog 2(12):
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Introduction
Pathogens are recognized by the immune system, which has
been divided into innate and adaptive responses. Innate
immunity detects pathogen-associated molecular patterns
(PAMPs) on the invading organisms [1]. PAMPs interact with
pattern recognition receptors, which often contain a cytosolic
region called the Toll/IL-1 receptor domain [2]. One group of
pattern recognition receptors, the Toll-like receptors (TLRs),
is evolutionarily conserved from Drosophila to humans and is
expressed by a variety of cell types [3]. Signaling through the
Toll/IL-1 receptor domains leads to activation of inﬂamma-
tory responses and initiation of adaptive immunity [4].
Another form of innate immunity (also known as intrinsic
immunity) appears as non-inducible barriers to pathogen
replication as exempliﬁed by apolipoprotein B mRNA-editing
enzyme catalytic polypeptides, which lead to the degradation
or mutation of viral genomes [5]. Finally, adaptive immunity
provides an antigen-speciﬁc response that can evolve and
provide immunological memory [4].
Pathogenic organisms have developed a number of
mechanisms to avoid innate, intrinsic, or adaptive immunity
or to modify these responses. Retroviruses, including the
betaretrovirus mouse mammary tumor virus (MMTV), repre-
sent one group of pathogens that uses cells of the immune
system to establish infection [6,7]. MMTV is transmitted as
exogenous virus through the milk of infected female mice to
newborn pups or through endogenous proviruses (Mtvs)
integrated in the germline [8]. Recently, we have shown that
MMTV is a complex retrovirus with features similar to the
human retroviruses, human endogenous retroviruses type K
(HERV-K), HIV, and human T-cell leukemia virus (HTLV) [9].
In the ﬁrst few weeks of life, milk-borne MMTV enters the
small intestine, where it penetrates M cells of the epithelial
layer to invade the underlying lymphoid tissue [10]. B
lymphocytes and dendritic cells are the initial targets of
MMTV infection [11]. These infected antigen-presenting cells
(APCs) express virus-encoded superantigen (Sag), a type II
transmembrane glycoprotein, at the cell surface in associa-
tion with major histocompatibility complex (MHC) class II
molecules [12]. Sag-MHC complexes on APCs interact with
particular variable regions on the b chains (Vb) of T-cell
receptors (TCRs) to initiate a helper T-cell response [11].
Unlike conventional antigens, these APC interactions allow
activation of 5% to 35% of naı ¨ve CD4þ T cells, which then
release cytokines to induce rapid proliferation of bystander
cells that are susceptible to MMTV infection [13]. Dividing
lymphocytes provide a reservoir of mobile infected cells,
which subsequently transmit MMTV to dividing mammary
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gradual deletion or anergy of the Sag-reactive T cells [15].
Thus, Sag plays an essential role in T-cell stimulation to
establish milk-borne MMTV infection. Disruption of T-B cell
interactions, which occurs in CTLA4 immunoglobulin-trans-
genic mice [16], or mice carrying several different knockout
mutations (Foxn1, immunoglobin heavy chain, CD40L, or
CD28) [17–20], reduces or abolishes the Sag-mediated
immune response as well as viral spread and transmission.
Common laboratory mice carry between two and eight Mtv
proviruses that often are defective for replication and fail to
produce infectious particles [21]. However, most Mtvs encode
functional Sags that induce intrathymic or peripheral
deletion of Sag-reactive T cells [22]. These Sags are
polymorphic at their C-termini, which interact only with
speciﬁc TCRs [23]. Thus, endogenous Mtv proviruses reshape
the adaptive immune system by altering the T-cell repertoire
of the mouse [24] and may potentially facilitate milk-borne
MMTV infection by generating partial tolerance to virally
encoded proteins. Further, mice transgenic for the sag gene of
C3H strain MMTV are protected against exogenous MMTVs
encoding the same Sag speciﬁcity, leading to the hypothesis
that endogenous Mtvs are maintained to provide protection
from milk-borne MMTV infection [6].
MMTV also interacts with the immune system through the
expression of the surface glycoprotein SU, which binds to the
transferrin receptor 1 (TfR1/CD71) to mediate viral entry into
host cells [25]. In addition, MMTV SU binds to TLR2 and
TLR4, and this interaction is believed to trigger the secretion
of proinﬂammatory cytokines and chemokines as well as the
upregulation of the entry receptor CD71 [26]. Cytokine
secretion is diminished from APCs if the cells have a double
mutation in TLR2 and TLR4 or if cells are tolerized by prior
exposure to lipopolysaccharide [26]. These results indicate
that MMTV manipulates both the innate and adaptive
immune responses through virally encoded SU and Sag.
In this study, we have developed BALB/c congenic mice
that lack all endogenous Mtvs (BALB/Mtv-null). These mice
are resistant to mammary tumorigenesis and leukemia
induction by two different MMTV strains, as well as mortality
induced by the Gram-negative pathogen, Vibrio cholerae. Both
viral and bacterial loads are diminished in Mtv-null animals
compared to their Mtv-positive littermates, and this pheno-
type is reversed by restoration of any one of three
endogenous Mtvs found in BALB/c mice. Since at least one
of the endogenous Mtvs appears to encode only superantigen,
our data suggest that MMTV Sag is a negative regulator of the
innate immune response to multiple pathogens.
Results
Development of a BALB/c Congenic Mouse Strain That
Lacks MMTV Proviruses
To obtain Mtv-null mice on the BALB/c background, we
mated BALB/c females (H-2
d) to males from the recently
inbred PERA/Ei (H-2
k) strain that lack endogenous Mtvs [27].
The F1 animals were then backcrossed to PERA mice to
obtain the N1 generation. Subsequently, N1 mice were
screened for the absence of endogenous Mtvs using PCR
from tail-derived genomic DNA, and Mtv-free progeny were
then mated to BALB/c mice. Every other generation, the
progeny were intercrossed to obtain Mtv-free animals that
were then backcrossed to BALB/c. This strategy was con-
tinued for ten generations to obtain the Mtv-null strain (H-
2
d), which has been maintained by brother-sister matings for
more than 3 y.
The absence of endogenous Mtvs was veriﬁed by PCR
analysis of mouse genomic DNA using primers speciﬁc for
each of the three endogenous MMTV proviruses of BALB/c
mice, Mtv6, 8, and 9 (Figure 1A). The lack of Mtvs was also
conﬁrmed by ﬂow cytometry to detect the levels of speciﬁc T
cells (Figure 1B). Deletion of speciﬁc T-cell subsets is a
sensitive indicator of the expression of MMTV superantigen
on the surface of antigen-presenting cells [28]. As expected,
BALB/c mice had very low levels of CD4þT cells reactive with
Sags encoded by Mtv6, 8, and 9 proviruses (TCR variable-
region beta [Vb] 3, 5, 7, and 12). However, signiﬁcant
populations of these same T-cell subsets were detected in
Mtv-null mice, consistent with the absence of the correspond-
ing endogenous MMTV proviruses. Further, Southern blot-
ting of genomic DNA from Mtv-null animals and
hybridization with MMTV long terminal repeat-speciﬁc
probes conﬁrmed the absence of proviruses (unpublished
data). Together, these data indicate that BALB/Mtv-null mice
are free from endogenous Mtvs.
BALB/Mtv-Null Mice Are Resistant to MMTV-Induced T-Cell
Deletion and Mammary Tumorigenesis
To determine the susceptibility of BALB/Mtv-null mice to
MMTV infection, Mtv-null pups were allowed to nurse on
C3H MMTV-infected mothers (C3H/HeN MMTVþ mice)
(foster nursing). This method allows the natural milk-borne
transmission of MMTV from mothers to offspring. As
anticipated, milk-borne MMTV infection of wild-type
BALB/c mice gave a 100% incidence of mammary tumors
with an average latency of 5.8 6 0.4 mo (Table 1). However,
milk-borne infection of Mtv-null mice only gave a 10%
incidence of mammary tumors (one of ten animals) with the
only tumor appearing at 15 mo.
Mice were also infected by inoculation with rat XC
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e128 1135
Susceptibility to Multiple Pathogens
Synopsis
Mouse mammary tumor virus (MMTV) is a retrovirus that causes
breast cancer in mice. MMTV-induced breast cancers represent a
well-established model for human breast cancer research. Mice
become infected by virus particles in mother’s milk (exogenous
MMTV), and insertion of exogenous MMTV into somatic cell DNA
sporadically leads to genetic damage and cancer. Alternatively, if
exogenous MMTVs infect germline cells, the viral genome becomes
a stable part of the mouse genome and may be inherited from
either parent (endogenous MMTV). In this report, the authors
demonstrate that mice carrying endogenous MMTV in their
genomes are more susceptible to disparate infectious agents, such
as exogenous MMTV and the cholera-producing bacteria, Vibrio
cholerae. However, this effect was selective since disease induced by
another related bacteria, Salmonella typhimurium, was not affected.
Genetic evidence suggests that a viral protein produced by
endogenous MMTVs enhances pathogen-induced disease and
death. Further, the human genome contains many human
endogenous virus type Ks, which highly resemble MMTVs and also
may influence disease. Therefore, this study suggests that endog-
enous retroviruses found in the mouse and human genomes alter
the course of disease induced by multiple pathogenic organisms.ﬁbroblasts stably expressing an infectious cloned MMTV
provirus, HYB-MTV [29]. The stably transfected cells (XC/
HYB-MTV) [30] were injected intraperitoneally into BALB/c
and Mtv-null weanlings. Wild-type mice developed mammary
tumors with an incidence of 90% and an average latency of
8.9 6 2.2 mo, whereas Mtv-null mice had a 10% mammary
tumor incidence (three of 29 animals inoculated) with an
average latency of 12.7 6 3.2 mo (Table 1). Therefore, the
difference between Mtv-null and BALB/c animals in disease
susceptibility was not inﬂuenced by the route of viral
infection.
One explanation for these results is that MMTV infection is
limited in Mtv-null mice and reduced replication of the virus
leads to a decreased frequency of proviral integration into
the cellular genome. MMTV is believed to induce tumors by
insertional mutagenesis and activation of cellular oncogenes
[31–33] and, therefore, reduced integration will limit mam-
mary tumor incidence. Since deletion of superantigen-
reactive T cells is a sensitive indicator of MMTV infection,
MMTV-infected animals were analyzed for Sag-speciﬁc T-cell
deletion.
As anticipated, wild-type BALB/c animals inoculated with
MMTV-infected rat cells showed statistically signiﬁcant (69%)
deletion of C3H MMTV Sag-reactive (CD4þVb14þ) T cells
compared to uninfected BALB/c mice (Figure 1C, left panel).
In contrast, Mtv-null mice inoculated with the same infected
cells showed no detectable C3H Sag-speciﬁc T-cell deletion
(Figure 1D, left panel). T-cell deletion was speciﬁc since there
was no observable deletion in a T-cell subset that is non-
reactive with C3H MMTV Sag protein (CD4þVb8þ; Figure 1C
and 1D, right panels). These results are consistent with the
idea that MMTV replication is restricted in Mtv-null mice,
thus reducing proviral loads and mammary tumorigenesis.
Deletion of Sag-speciﬁc T cells was also not detectable in
progeny of MMTV-infected Mtv-null mothers (unpublished
data).
To determine whether there was a difference in viral loads
between MMTV-inoculated BALB/c and Mtv-null mice, spleen
RNA was obtained from multiple infected animals and
subjected to semi-quantitative RT-PCR using long terminal
repeat primers that were speciﬁc for C3H MMTV (Figure 2A).
Exogenous MMTV RNA levels were consistently higher in
BALB/c mice than in Mtv-null animals inoculated with HYB-
MTV infected cells. Similar data were obtained using tissues
from mice infected with MMTV by foster nursing (Figure 2A).
Also, note that MMTV RNA was barely detectable in Mtv-null
mammary tumors (Figure 2A, lane 18, and unpublished data),
but was easily detected in the BALB/c tumors (lanes 19 and
20). These results indicate that Mtv-null mice have reduced
viral loads after MMTV infection.
Figure 1. BALB/Mtv-Null Mice Lack Endogenous Mtvs and Have Impaired Sag-Mediated T-Cell Deletion after Exogenous MMTV Infection
(A) PCR analysis of mouse genomic DNA using endogenous Mtv-specific primers. Genomic DNA samples from mice with single endogenous Mtvs were
used as positive controls for PCR amplification of individual proviruses (lanes 2–4). Genomic DNA samples from three Mtv-null mice were analyzed (lanes
5–7). PCR with no added DNA template was the negative control (lane 8).
(B) Flow cytometry of endogenous Mtv Sag-reactive T-cell subsets in PBLs. PBLs from 6-mo-old BALB/c and Mtv-null mice were dually stained with
mouse specific CD4-phycoerythrin and mouse-specific TCR Vb3, 5, 7, or 12-FITC antibodies followed by FACS and software analysis. Three individual
animals of each strain were tested, and the average proportion of T-cell subsets (6 standard deviation) is shown. Flow cytometry also was performed on
PBLs isolated after MMTV infection of BALB/c J (C) or Mtv-null (D) mice. The numbers inside the bars indicate the numbers of animals tested. At 11 mo
post-infection of BALB/c animals, only two animals were tested for T-cell deletion because the other animals had died from mammary tumors. Cells
were stained with mouse-specific CD4-PE and mouse-specific Vb8o rV b14-FITC antibodies. The percentages of C3H MMTV Sag-reactive (CD4þVb14þ)
(left panels) and non-reactive (CD4þVb8þ) (right panels) T cells among the PBLs isolated from mice inoculated with C3H MMTV-infected rat cells (dark
bars) were compared to non-injected control mice (light bars). PE, phycoerythrin.
doi:10.1371/journal.ppat.0020128.g001
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Lymphomas
Sag-mediated ampliﬁcation of MMTV in lymphoid cells is
required for efﬁcient viral transmission and dissemination in
the mammary gland [6,14]. Therefore, resistance of Mtv-null
mice to MMTV-induced disease could be attributed to
reduced Sag function in these animals. To test this possibility,
we analyzed infection by an MMTV variant, TBLV, which
induces T-cell tumors rather than mammary cancers [34,35],
by a Sag-independent mechanism [34]. Injection of TBLV-
infected cells intraperitoneally into weanling BALB/c mice
gave a 50% incidence of T-cell lymphomas with an average
latency of 5.7 mo. In contrast, BALB/Mtv-null mice inoculated
in the same manner failed to develop lymphomas within the
10-mo observation period (Table 1). Similarly, BALB/Mtv-null
mice did not develop lymphomas after injection with a TBLV
mutant that encodes only 17 amino acids of Sag, whereas this
same mutant was lymphomagenic in BALB/c mice (unpub-
lished data) [34]. Thus, both Sag-dependent and Sag-
independent MMTV strains have reduced tumorigenicity in
Mtv-null mice.
To test whether resistance of Mtv-null mice affects viral
replication, we performed RT-PCR analyses on RNA ex-
tracted from tissues of TBLV-inoculated mice. TBLV tran-
scripts were detected by RT-PCR in splenic RNA from 10-mo-
old infected animals, and the identity of PCR products was
conﬁrmed by sequencing (Figure 2B and unpublished data).
Viral loads were greatly reduced in the infected Mtv-null mice
compared to those from infected BALB/c animals. Since viral
RNA was detected only sporadically, our results suggest that
Mtv-null mice are less susceptible to MMTV and TBLV
infection. Nevertheless, viral RNA cannot be demonstrated in
every organ of MMTV or TBLV-infected wild-type BALB/c
mice (unpublished data), a result that might be expected from
the negative regulation of MMTV transcription in most
tissues except lactating mammary gland [36,37]. Together
with the lack of Sag-speciﬁc T-cell deletion observed in Mtv-
null mice infected by MMTV (Figure 1), these experiments
suggest that Mtv-null mice restrict both TBLV and MMTV
replication.
MMTV Resistance Is Recessive and Segregates with
Endogenous MMTV Proviruses
To determine the gene(s) involved in the resistance of
BALB/Mtv-null mice to MMTV and TBLV infection, we
obtained F1 hybrids between BALB/c and Mtv-null mice.
Weanling F1 animals were injected intraperitoneally with
MMTV-infected rat cells and observed for Sag-reactive T-cell
deletion and development of mammary tumors. Deletion of
C3H-MMTV Sag-speciﬁc (Vb14þ) T cells was detected in all
MMTV-infected F1 animals similar to that observed with
infected wild-type BALB/c mice (Figure 3A). Deletion was not
observed in the Sag non-reactive T-cell population (Vb8þ)
(Figure 3F). The injected F1 mice also developed mammary
tumors with an incidence of 86% and an average latency of
7.3 6 2.4 mo (see below; Table 1). RT-PCR was used to
identify expression of C3H MMTV in these tumors. As
anticipated, these tumors expressed MMTV RNA as detected
by RT-PCR, and cleavage of the products with ClaI was
consistent with the presence of C3H MMTV transcripts
(unpublished data). Therefore, resistance of the Mtv-null mice
to mammary tumors as well as Sag-speciﬁc T-cell deletion is a
recessive trait.
During the establishment of the Mtv-null strain, we noted
that the resistance to MMTV-induced mammary tumors was
retained after six backcross generations. This result suggested
that resistance is a multi-gene trait. To determine whether
the resistance of Mtv-null mice segregates with any of the
endogenous Mtv loci of BALB/c mice, we derived BALB/c
congenic strains carrying single Mtv proviruses called BALB/
Mtv6, BALB/Mtv8, and BALB/Mtv9 (single-positive strains).
The same crosses also yielded siblings that lacked all three
endogenous MMTV proviruses. The presence or absence of
endogenous Mtvs in these strains was veriﬁed by PCR analysis
of genomic DNA and by ﬂow cytometry of peripheral blood
lymphocytes (PBLs) (unpublished data).
Table 1. Tumor Incidence of Mice Infected with MMTV or TBLV
Mouse Strain Infection By:
Foster Nursing with C3H MMTV
a Intraperitoneal Inoculation with MMTV
b Intraperitoneal Inoculation with TBLV
c
Tumor Incidence
(Number of Mice
with Tumors/Total)
d
Average
Latency (mo)
e
Tumor Incidence
(Number of Mice
with Tumors/Total)
d
Average
Latency (mo)
e
Tumor Incidence
(Number of Mice
with Tumors/Total)
f
Average
Latency (mo)
e
BALB/c 100% (6/6) 5.8 6 0.4 90% (9/10)
d 8.9 6 2.2 50% (9/18) 5.7 6 1.5
Mtv-null 10% (1/10) 15 10% (3/29) 12.7 6 3.2 0% (0/8) —
BALB/cX
Mtv-null
ND
g ND 86% (12/14) 7.3 6 2.4 ND ND
BALB/Mtv6 ND ND 38% (5/13) 12.8 6 1.8 ND ND
BALB/Mtv8 ND ND 75% (6/8) 9.1 6 3.6 ND ND
BALB/Mtv9 ND ND 53% (8/15) 8.6 6 2.3 ND ND
aNewborn animals were infected by nursing on MMTV-infected C3H/HeN mothers.
bWeanling animals were infected by intraperitoneal inoculation with rat XC cells stably transfected with an infectious MMTV provirus.
cWeanling animals were infected by intraperitoneal injection of human Jurkat T cells stably transfected with an infectious TBLV provirus.
dNumber of female mice with mammary tumors/total number of infected females. Mice that died before 12 mo of age from birthing problems were excluded from the study.
eMean 6 standard deviation.
fNumber of animals with T-cell lymphomas/total number of infected males and females.
gNot done.
doi:10.1371/journal.ppat.0020128.t001
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peritoneally with MMTV-infected rat cells and observed for
deletion of Sag-reactive T cells and for the development of
mammary tumors. Interestingly, all three single-positive
strains demonstrated equivalent C3H MMTV-speciﬁc T-cell
deletion with similar kinetics (Figure 3B–3D). Deletion of
CD4þVb14þT cells at 9 mo post-inoculation was 38% (BALB/
Mtv6), 48% (BALB/Mtv8), and 45% (BALB/Mtv9). As expected,
BALB/Mtv-null siblings showed no deletion (Figure 3E).
Moreover, the Sag non-reactive T-cell population (Vb8þ)
was not affected (Figure 3F–3J), validating the speciﬁcity of
the deletion observed.
Mice carrying single Mtv proviruses were also susceptible to
C3H MMTV-induced mammary tumors (Table 1). Interest-
ingly, the incidence of mammary tumors correlated with the
extent of T-cell deletion. The incidence of tumors was highest
in BALB/Mtv8 mice (75%), whereas the tumor incidence was
53% and 38% in BALB/Mtv9 and BALB/Mtv6 mice, respec-
tively. Three of the 29 injected Mtv-null mice also developed
mammary tumors (;10% incidence). The tumor incidence of
BALB/c mice carrying single Mtv proviruses was statistically
higher than those lacking MMTV proviruses. Expression of
C3H MMTV RNA was veriﬁed in mammary tumors using RT-
PCR with virus-speciﬁc primers followed by cleavage of the
products with ClaI (unpublished data). Because Mtv6, 8, and 9
are located on different mouse chromosomes, these results
suggest that susceptibility to Sag-mediated deletion and
mammary tumorigenesis is conferred by the presence of
any of three endogenous Mtv proviruses rather than linked
cellular genes.
BALB/Mtv-Null Mice Infected with MMTV Lack a
Neutralizing Antibody Response
Since a single endogenous Mtv provirus is sufﬁcient to
allow Sag-mediated deletion and MMTV-induced mammary
t u m o r s ,i ti sp o s s i b l et h a tB A L B / cm i c eh a v ei m m u n e
tolerance to MMTV-encoded proteins. If this is true, then
Mtv-null mice may have a strong neutralizing antibody
response against virion antigens that limits the infection
[38]. To test this idea, BALB/c and Mtv-null mice were
infected by nursing on MMTV-infected C3H/HeN mothers
and then tested at weekly intervals for MMTV-speciﬁc
antibodies by an enzyme-linked immunosorbent assay (ELI-
SA) (Figure 4A). The majority of BALB/c mice lacked virus-
speciﬁc antibodies (;94% of the animals) during the ﬁrst 3–5
wk of age as reported previously [39]. Similarly, antibodies
directed against MMTV were absent in 70% of the Mtv-null
animals, despite use of a more sensitive assay as compared to
previous reports [39]. To test the speciﬁcity of the sporadi-
cally occurring, low-titer antibodies, Western blots of puriﬁed
MMTV were incubated with sera from individual Mtv-
negative animals infected by milk-borne MMTV (Figure 4B).
No envelope (SU)-speciﬁc antibodies were detectable,
although some reactivity to capsid protein was demonstrable.
Since only a small percentage of the resistant animals
developed antibodies and the antibodies were not directed
against surface antigens, the resistance of Mtv-null mice to
MMTV-induced mammary tumors is not due to production
of neutralizing antibodies. Therefore, the mechanism of viral
resistance in Mtv-null mice does not resemble antibody-
mediated mechanism(s) reported for other mouse strains that
limit MMTV infection [38,39].
Mtv-Null Mice Have an Immune Response to MMTV-
Infected, but Not Uninfected, BALB/c Lymphoma Cells
The resistance of Mtv-null mice to MMTV infection may
result from a cell-mediated immune response to the virus. To
test this idea, weanling BALB/c and Mtv-null animals were
inoculated intraperitoneally with 5 310
6 A20 cells (a BALB/c
B-cell lymphoma cell line) [40]. A second set of mice was
injected with the same number of A20 cells stably transfected
with an infectious MMTV provirus, HYB-MTV. Injection of
A20 cells gave approximately the same percentage of solid,
peritoneal tumors in both BALB/c and Mtv-null mice (25% [3/
12] with an average latency of 7.5 6 1.5 wk versus 29% [4/14]
with an average latency of 6.8 6 2.3 wk). In contrast, 38% (5/
13) of BALB/c (average latency 5.2 6 0.5 wk), but none of the
Mtv-null mice developed tumors when injected with MMTV-
transfected A20 cells. Therefore, these results suggest that
Mtv-null mice can direct a speciﬁc immune response against
C3H MMTV-infected cells.
Resistance of BALB/Mtv-Null Mice to V. cholerae Correlates
with Absence of Endogenous Mtvs
Since the resistance of Mtv-null mice to TBLV and MMTV
infection may be due to an immune response, we tested
whether these mice may also have an altered disease
susceptibility to other pathogens. BALB/c and Mtv-null mice
were inoculated intragastrically with V. cholerae strain O395,
Figure 2. Exogenous MMTV RNA Loads Are Higher in the Presence of
Endogenous Mtv Proviruses
(A) RT-PCR indicates higher levels of C3H MMTV RNA in spleens derived
from infected BALB/c mice compared to those from infected Mtv-null
mice. The numbers above each lane represent separate BALB/c or Mtv-
null animals as indicated. Mice injected with cloned HYB-MTV-producing
cells are designated HM, whereas mice infected by foster-nursing are
designated F. Organs were harvested between 6–15 mo post-infection in
BALB/c mice at the time of tumor development, whereas organs from
Mtv-null mice were harvested between 10–15 mo post-infection. MT,
mammary tumor
(B) RT-PCR analysis shows lower TBLV levels in Mtv-null versus Mtv-
positive strains. Organs were harvested between 4–10 mo post-infection
in BALB/c mice at the time of tumor development; organs from Mtv-
negative mice were obtained at 10 mo post-infection.
doi:10.1371/journal.ppat.0020128.g002
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Susceptibility to Multiple Pathogenswhich expresses cholera toxin [41]. Mid-log phase bacterial
suspensions containing 10
5,1 0
6,o r1 0
7 colony-forming units
(CFUs) were fed to 5- to 6-d-old pups, and mortality was
recorded over a 48-h period. As anticipated, the average lethal
dose (LD50)o fV. cholerae in BALB/c mice was 1.6 3 10
5 CFUs
(Table 2). In contrast, the average LD50 of V. cholerae in Mtv-
null animals was ;16-fold higher (2.33 10
6 CFUs) (p , 0.05).
These results indicate that Mtv-null mice are more resistant
than BALB/c mice to two different pathogens, MMTV and V.
cholerae. The difference in disease resistance of the two mouse
strains to V. cholerae can be observed within 24 h.
To evaluate whether the increased resistance to V. cholerae
of Mtv-null mice was linked to the absence of endogenous
Mtvs, the disease susceptibility of mouse strains carrying
single Mtv proviruses on the BALB/c background was
evaluated after intragastric inoculation of pups. The average
LD50 values of the BALB/Mtv6, BALB/Mtv8, and BALB/Mtv9
strains were 2.2 3 10
5, 1.2 3 10
5, and 2 3 10
5 CFUs,
respectively, which were similar to that of the parental
BALB/c strain (Table 2). Statistical analysis revealed that the
LD50 values for V. cholerae in Mtv-null mice were signiﬁcantly
higher (p , 0.05) than those of BALB/c mice or mice carrying
single Mtvs. Similar experiments were performed using
intragastric inoculation of adult mice with Salmonella typhi-
murium; however, no statistical difference in mortality was
observed between Mtv-null and BALB/c mice (unpublished
data).
To determine whether the difference in susceptibility to V.
cholerae was due to differences in cholera-toxin–induced ﬂuid
accumulation or due to altered bacterial growth, additional
BALB/c and Mtv-null pups were inoculated with several
different doses of bacteria. Our data revealed that there was
little difference in relative ﬂuid accumulation in the guts of
the two strains (unpublished data), whereas growth in the
small intestines of Mtv-null strain animals was statistically
lower than that in wild-type BALB/c mice after inoculation
with three different doses of V. cholerae (Figure 5).
Discussion
BALB/c congenic mice that lack all endogenous Mtvs were
resistant to mammary tumors induced by MMTV, lymphomas
induced by TBLV, and mortality due to V. cholerae. In each
case, pathogen infection could be demonstrated. However,
the viral load was reduced in MMTV-infected Mtv-null mice
as demonstrated by negligible amounts of Sag-speciﬁc T-cell
deletion and by reduced levels of MMTV or TBLV RNA in
infected tissues. Relative resistance to MMTV was not affected
by the method of inoculation. V. cholerae infection of Mtv-null
Figure 3. BALB/c X Mtv-Null F1 Hybrids and Mice Carrying Single Mtv Proviruses Exhibit C3H MMTV Sag-Specific T-Cell Deletion
PBLs isolated from MMTV-infected (dark bars) and control non-infected (light bars) mice at different times were dually stained with mouse-specific CD4-
PE and Vb8o rV b14-FITC antibodies followed by FACS analysis. The percentages of C3H Sag-reactive CD4þVb14þ(A–E) and non-reactive CD4þVb8þ(F–
J) T cells obtained from BALB/c X Mtv-null F1 (A and F), BALB/Mtv6 (B and G), BALB/Mtv8 (C and H), BALB/Mtv9 (D and I), and BALB/Mtv-null (E and J) are
depicted. Numbers inside the bars represent numbers of animals tested. The average percentages of T cells in the MMTV-infected Mtv-positive strains
(including standard deviation) were significantly different from non-infected controls of the same strains by the two-tailed Student’s t test (p , 0.05)
(asterisks). In contrast, infected Mtv-null animals failed to demonstrate T-cell deletion. PE, phycoerythrin.
doi:10.1371/journal.ppat.0020128.g003
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Susceptibility to Multiple Pathogensanimals also led to reduced bacterial loads compared to those
observed in BALB/c mice.
Several mechanisms of resistance to MMTV infection have
previously been described. A number of these mechanisms
involves disruption of Sag-induced interactions of B and T
cells, which are required for ampliﬁcation of the number of
milk-borne MMTV-infected cells and transmission of virus to
the mammary gland [6,7,18]. Transgenic mice expressing high
levels of C3H MMTV Sag delete their Sag-reactive T cells and
are refractory to milk-borne C3H MMTV infection [6]. A
similar phenotype has been reported in Vb8.2-transgenic
mice, which cannot be infected by SW MMTV whose Sag does
not recognize Vb8.2þ T cells [7]. B-cell-deﬁcient mice are
resistant to milk-borne MMTV infection as demonstrated by
their failure to delete Sag-reactive T cells and the absence of
proviral integrations in spleen and mammary glands [18].
Further, mice with inefﬁcient presentation of MMTV Sag due
to MHC class II mutations are resistant to viral infection [42].
Knockout mice deﬁcient in cell surface molecules necessary
for T-B cell interactions (CD28/CTLA4-B7 or CD40/CD40L)
also demonstrate defects in milk-borne MMTV dissemination
and transmission [16,19,20]. Thus, the resistance of Mtv-null
mice to MMTV-induced tumorigenesis might be attributed to
lack of Sag-mediated viral ampliﬁcation in the lymphoid
compartment.
Two lines of evidence argue against a defect in Sag-
mediated ampliﬁcation in Mtv-null animals. First, these mice
are resistant to TBLV-induced lymphomas (Table 1). TBLV
encodes a truncated Sag protein that lacks the C-terminal
domain necessary for interaction with the Vb region of the
TCR and does not induce Sag-mediated deletion after
infection, yet induces T-cell lymphomas in susceptible
BALB/c mice [34,43]. Second, Mtv-null animals are resistant
to tumorigenesis by the TBLV sag-frameshift virus (unpub-
lished data). Published results indicate TBLV variants
engineered with a double-frameshift mutation in the trun-
cated sag gene induced lymphomas with the same efﬁciency as
wild-type TBLV [34]. Failure of TBLV or TBLV sag frameshift
viruses to induce tumors in Mtv-null mice suggests that
resistance is linked to a host immune response at a step
upstream of the Sag response, but common to both MMTV
and TBLV infections.
Table 2. Resistance of Mtv-Null Mice to Disease Induced by V.
cholerae Is Abolished by the Presence of a Single Mtv Provirus
Mouse
Strain
Number
Animals
Tested
LD50 at 48 h
Post-Infection
(Standard Deviation)
p-Value
a
BALB/c 31 1.6 3 10
5 (6 8 3 10
4). 0 3
BALB/Mtv-null 42 2.3 3 10
6 (6 2 3 10
6)—
BALB/Mtv6 38 2.2 3 10
5 (6 1 3 10
5). 0 3
BALB/Mtv8 31 1.2 3 10
5 (6 4 3 10
4). 0 3
BALB/Mtv9 41 2.0 3 10
5 (6 9 3 10
4). 0 2
aSingle-factor ANOVA followed by Tukey’s post-hoc tests were performed using SPSS 12.0.
The p-values were obtained from pair-wise comparisons of each mouse strain with the
BALB/Mtv-null strain.
doi:10.1371/journal.ppat.0020128.t002
Figure 4. BALB/Mtv-Null Mice Infected by Milk-Borne MMTV Lack Virus-Specific Neutralizing Antibodies
(A) Both BALB/c and Mtv-null animals sporadically have low levels of MMTV-specific antibodies. Sera from milk-borne C3H MMTV-infected (gray
symbols) or age-matched non-infected (white symbols) BALB/c (squares) and Mtv-null (circles) mice were analyzed weekly by ELISA to detect virion-
specific antibodies. Each symbol represents an individual mouse. The serum antibody titer was calculated as the reciprocal of the highest serum dilution
that reacted with MMTV virions. Since one non-infected animal showed a titer of 1:80, values above 1:100 (the heavy line) were considered positive.
(B) Sporadic, low-titer antibodies in Mtv-null animals have reactivity to MMTV capsid antigen. Proteins from purified MMTV particles were separated on
SDS-containing polyacrylamide gels, subjected to Western blotting, and incubated with a 20-fold dilution of serum from two MMTV-infected Mtv-null
mice with the highest antibody titers (1:320) at 4–5 wk of age. MMTV capsid antigen (CA) or surface envelope (SU)-specific monoclonal antibodies were
used as positive controls. Sera from two age-matched non-infected BALB/Mtv-null mice were used as negative controls.
doi:10.1371/journal.ppat.0020128.g004
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Susceptibility to Multiple PathogensProduction of a neutralizing antibody response has been
shown to prevent induction of MMTV-induced mammary
tumors [38,39]. The I/LnJ mouse strain, which contains
endogenous Mtvs, produces IgG2a MMTV-speciﬁc neutraliz-
ing antibodies that block viral transmission from lymphoid to
mammary gland cells. Unlike the MMTV-susceptible BALB/c
strain, production of antibodies in this strain is sustained and
dependent on interferon c [39]. Experiments in BALB.D2
mice, which lack endogenous Mtvs, have also shown that a
neutralizing antibody response does not dramatically inter-
fere with viral ampliﬁcation in lymphoid cells, but limited
infection of the mammary gland [38]. In contrast, the BALB/
Mtv-null mice show only low level, sporadic infection of
lymphoid organs, and no transmission is demonstrable to
progeny. I/LnJ and BALB.D2 mice both showed a signiﬁcant
MMTV Sag response following infection [38,39], whereas
BALB/Mtv-null animals did not. The experiments in BALB.D2
mice appeared to involve incomplete backcrossing between
the BALB.D2 and 38CH strains, which may account for some
of the differences with our results. Further, the BALB.D2
results were obtained with SW MMTV, which is known to
induce a strong Sag response in adult mice, but causes
mammary tumors at a low incidence [38]. Therefore, Mtv-null
mice appear to demonstrate a unique genetic mechanism of
resistance to MMTV.
To our knowledge, our data represent the ﬁrst report that a
retroviral susceptibility mechanism may extend to bacteria.
Previous reports from the Benjamin lab indicated that
endogenous Mtv7 Sag-mediated deletion of TCR Vb6þ cells
renders mice susceptible to polyomavirus-induced tumors
[27,44]. This observation resulted from the absence of a TCR
Vb6þ population of polyoma-speciﬁc cytotoxic T lympho-
cytes (CTLs). In contrast, our studies show that any one of
three BALB/c endogenous MMTVs with different Sag
speciﬁcities was necessary and sufﬁcient to confer suscepti-
bility to completely disparate pathogens. Since the resistance
to both MMTV and V. cholerae is observed in the very early
stages of primary infection (within 24 h for V. cholerae), it is
unlikely that Sag-mediated removal of CTLs is the primary
reason for susceptibility to infection in the presence of
endogenous MMTVs. Our results also raise interesting
questions regarding the evolution and maintenance of
endogenous Mtvs in mouse populations. The dynamic
compromise for mutual survival of both MMTV and the
mouse will be inﬂuenced by complex interactions between
the MMTV-modulated murine immune system and numerous
environmental pathogens.
Although the exact process leading to MMTV disease
susceptibility in BALB/Mtv-null animals remains to be
determined, several clues are available. An enhanced immune
response to MMTV-encoded proteins was observed in Mtv-
null mice, consistent with proposals that there is immuno-
logical intolerance to viral antigens in the absence of
endogenous proviruses [38]. However, Mtv-null mice were
resistant to both MMTV and V. cholerae, which share few, if
any, antigenic determinants, and virus infection could be
detected in Mtv-null organs, even as long as 15 mo post-
infection. Further, susceptibility of mice to MMTV and V.
cholerae was reconstituted by any one of three endogenous Mtv
proviruses, Mtv6, Mtv8, or Mtv9. One of these proviruses,
Mtv6, lacks .6 kb of sequence encoding most of gag and env,
as well as the entire pol gene [45], thus eliminating most of the
immunodominant CTL epitopes [46]. These results suggest
that (i) an MMTV-encoded gene product confers suscepti-
bility to two disparate pathogens, and (ii) the viral product is
not encoded by the gag, pol, or env genes.
The Mtv6 provirus is believed to encode only a single
mRNA, which has been functionally shown to encode Sag
[47], and our data are consistent with these observations
(unpublished data). Since Mtv6 confers susceptibility to V.
cholerae very early after infection, we suggest that MMTV Sag
acts as a negative regulator of innate or intrinsic immunity.
Failure to suppress innate immunity would explain early
effects on bacterial and viral loads in Mtv-null animals, as
well as their heightened ability to use the adaptive CTL
response to reject C3H MMTV-expressing tumor cells. A
common feature of the innate immune response to both V.
cholerae and MMTV is the ability to signal through TLR4
[26,48,49]. Lipopolysaccharide of Gram-negative organisms,
such as V. cholerae, as well as the MMTV envelope protein, SU,
both bind to TLR4 to stimulate an immune response [26,48].
Although bacterial superantigens of Gram-positive bacteria
appear to increase TLR4 mRNA and protein levels [50], our
preliminary experiments have detected no differences in the
surface TLR4 expression of BALB/c and BALB/Mtv-null
macrophages. In support of these results, the LD50 values of
BALB/c and Mtv-null mice for V. cholerae O395 treated with
formalin (which preserves lipopolysaccharide, but inactivates
infectivity) are not signiﬁcantly different, and no differences
in susceptibility to S. typhimurium were noted (unpublished
data). Thus, Sag or an unknown MMTV-encoded product
may manipulate novel aspects of innate or intrinsic
immunity. Our studies suggest that many mouse models of
human disease may be affected by the presence of endoge-
nous MMTV proviruses. Furthermore, the ability of the
related HERV-K proviruses to encode superantigens raises
the possibility that human retroviruses alter the innate or
intrinsic immune responses to pathogens.
Figure 5. Bacterial Load Is Decreased in Mtv-Null Mice
Three different doses of V. cholerae were given to 5- to 6-d-old pups
(three to four animals/dose). After 24 h, the mice were sacrificed, and the
small intestines were assayed for bacterial growth. The means (numbers
shown inside bars) and standard deviations for the recovered CFUs of
each set of animals are indicated. Two-tailed Student’s t tests were used
for pair-wise comparisons of BALB/c and Mtv-null animals infected at
each dose; p-values of ,0.05 are shown by an asterisk.
doi:10.1371/journal.ppat.0020128.g005
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Mice. BALB/cJ (H-2
d, Mtv6, 8, and 9-positive) and PERA/Ei (H-2
k,
Mtv-free) [51] mice were obtained from The Jackson Laboratory
(http://www.jax.org). Mice were bred and maintained in the Animal
Resources Center at the University of Texas, Austin, Texas, United
States. BALB/Mtv-null mice (H-2
d) lacking endogenous Mtvs were
selected from a BALB/cJ X PERA/Ei cross followed by more than ten
intercross and backcross generations; these animals have .99.9%
BALB/c background. BALB/Mtv6, BALB/Mtv8, and BALB/Mtv9 mice
were derived by crosses between BALB/cJ and BALB/Mtv-null animals
and screened by PCR and FACS analysis of PBLs for the presence of
the appropriate single Mtv proviruses. Mice were tested periodically
to ensure the absence of common bacterial and viral pathogens.
Infections. Animals infected by the milk-borne route were nursed
on MMTV-positive C3H/HeN mothers. In other experiments,
weanling 4- to 5-wk-old BALB/c, BALB/Mtv-null, or congenic mice
containing single Mtvs were injected intraperitoneally with 2 3 10
7
XC/HYB-MTV or Jurkat/HYB-TBLV cells. The XC- transfected cells
were cultured in 10 lM dexamethasone (Sigma, http://www.
sigmaaldrich.com) for 18 h prior to injection. All injected females
were bred continuously to stimulate lactogenic hormones. For
determination of LD50 values, single colonies of V. cholerae O395
were grown in overnight cultures, diluted 100-fold, and then cultured
to an A650¼0.5 (;5310
8 CFUs). Appropriate dilutions of bacteria in
50 ll of phosphate-buffered saline (PBS) containing 0.02% (w/v)
Evan’s blue dye were given intragastrically to 5- to 6-d-old pups,
which were monitored for 48 h as previously described [52,53]. The
doses of inoculated bacteria were conﬁrmed by plating onto L agar
containing 67 lg per ml streptomycin. LD50 values were calculated by
the method of Reed and Muench [54]. In some cases, the small
intestines were recovered at 24 h post-inoculation and homogenized
in 1 ml of PBS prior to determination of bacterial counts on
streptomycin-containing L agar. To determine the LD50 values for S.
typhimurium SL1344, an isolated colony was cultured overnight at 37
8C, diluted 100-fold, and then grown to an A600 of 0.7 (;7 3 10
8
CFUs). Appropriate bacterial dilutions were prepared in PBS
containing 5% sucrose and inoculated intragastrically using a gavage
needle into 4- to 6-wk-old mice that had been starved for 18–20 h.
Morbidity/mortality was determined during a 14-d observation
period.
Cells. XC rat ﬁbroblast cells were stably transfected with the hybrid
MMTV provirus, pHYB-MTV [29] (referred to as XC/HYB-MTV). The
human Jurkat T-cell line was stably transfected with the hybrid TBLV
provirus (pHYB-TBLV) (referred to as Jurkat/HYB-TBLV) [34].
Culture conditions have been described [55].
Flow cytometry. Mice were bled from the retroorbital sinus at
regular intervals, and PBLs were isolated and stained as previously
described [56]. Fluorescein- or phycoerythrin-labeled antibodies were
obtained from BD Biosciences Pharmingen (http://www.
bdbiosciences.com). Cells were analyzed on a FACSCalibur using
CELLQuest software (BD Biosciences).
PCR and RT-PCR analysis. Tail DNA for PCR analysis was
extracted as described by The Jackson Laboratory and used for
PCR with speciﬁc primers (Table S1). Initial PCR assays were
performed using PCR Supermix (GIBCO-BRL, Invitrogen, http://
www.invitrogen.com), but later assays used JumpStart REDAccu-
Taq
TM (Sigma) according to the manufacturer’s instructions. Total
RNA was extracted from tissues as described [56], and 20 lg was
treated with 3 U of ampliﬁcation grade DNase I (Invitrogen) at 37 8C
for 30 min. The DNase was inactivated, and the RNA was reverse
transcribed using 400 U of Moloney murine leukemia virus reverse
transcriptase (RT) (Invitrogen) according to the manufacturer using
poly-dT17 as primer. Reactions without RT veriﬁed the lack of DNA
contamination. Five ll of the reactions were ampliﬁed in a 50-ll
volume containing 50 mM Tris-HCl (pH 9.1), 16 mM ammonium
sulfate, 3.5 mM MgCl2, 150 lg/ml bovine serum albumin, 0.3 mM
deoxynucleotide triphosphates, 100 ng of each primer, and 2.5 U of
KlenTaq polymerase (AB Peptides, http://www.abpeps.com). 30 or 40
cycles of denaturation at 94 8C for 1 min, annealing at 55 8C for 1
min, and extension at 72 8C for 1 min in a PTC-100 Programmable
Thermal Controller (MJ Research, Bio-Rad, http://www.bio-rad.com)
were followed by a 5-min extension at 72 8C. Primers for these
reactions are listed (Table S1). 40 cycles were used to maximize the
detection of any RNA expression in Mtv-null animals. Samples were
analyzed by electrophoresis on 2% agarose gels. In some cases, the
products were puriﬁed using a QIAquick gel extraction kit (Qiagen,
http://www1.qiagen.com) and sequenced. Restriction fragment length
polymorphisms were used to differentiate between RT-PCR products
ampliﬁed from exogenous C3H MMTV and endogenous Mtvs.
Products were puriﬁed through Micro Bio-Spin P-30 columns (Bio-
Rad Laboratories) and incubated with ClaI for 2 h at 37 8C after
addition of a plasmid digestion control in each reaction. Major
fragments were isolated and conﬁrmed by sequencing.
ELISA and Western blotting. MMTV virion proteins were used in
ELISA to detect MMTV-speciﬁc antibodies as previously described
[39], except that a higher concentration of puriﬁed virus (10 lg/ml)
was used for coating of the wells to increase sensitivity. Serum
samples were obtained by retroorbital bleeds. Western blots were
performed according to Mustafa et al. [30].
Statistical analysis. Pair-wise comparisons were performed by the
two-tailed Student’s t test. Statistics for MMTV-induced tumors were
performed using the LIFETEST procedure in SAS8.2 to compute
non-parametric estimates of the survivor function by the product-
limit method (also known as the Kaplan-Meier method). The
homogeneity of survival functions across groups was tested using
log-rank and Wilcoxon tests. V. cholerae infections of different groups
of mice were analyzed by single-factor ANOVA followed by Tukey’s
post-hoc test using SPSS 12.0; p-values of ,0.05 were considered
signiﬁcant.
Supporting Information
Table S1. Primers Used for PCRs and RT-PCRs
doi:10.1371/journal.ppat.0020128.st001 (31 KB DOC).
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